Every record from Janoshik · page 62
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-020281 | Enclomiphene citrate | MKM | MKM-2408-L2880 | 2025-Q1 | 98.12 | 4.20 | 103.7 | Supplier-supplied | 1 | FAIL |
| AX-2025-019056 | KPV | JEEP | JEEP-2410-C3420 | 2025-Q1 | 99.60 | 5.41 | 96.0 | Supplier-supplied | 0 | FAIL |
| AX-2025-018832 | CJC-1295 (no DAC) | QSC | QSC-2411-D9076 | 2025-Q1 | 98.64 | 3.40 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020063 | Tirzepatide | ERP | ERP-2502-T7984 | 2025-Q1 | 98.30 | 3.93 | 88.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019824 | Enclomiphene citrate | SWB | SWB-2410-V4278 | 2024-Q4 | 99.72 | 6.07 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-021175 | BPC-157 | WXT | WXT-2412-Y6192 | 2025-Q1 | 99.38 | 7.31 | 90.2 | Laboratory-retained | 3 | MARGINAL |
| AX-2025-019527 | L-Glutathione (reduced) | Homopeptide | HOMO-2501-D9486 | 2025-Q1 | 98.83 | 9.30 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019684 | IGF-1 LR3 | HJ | HJ-2410-G2561 | 2025-Q1 | 97.46 | 3.82 | 95.5 | Supplier-supplied | 0 | PASS |
| AX-2025-018572 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.93 | 3.66 | 91.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018569 | Retatrutide | WWB | WWB-2412-N4087 | 2025-Q1 | 99.76 | 3.00 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021006 | GHRP-6 | WXT | WXT-2411-G3549 | 2024-Q4 | 98.48 | 3.10 | 89.1 | Supplier-supplied | 3 | FAIL |
| AX-2025-020626 | TB-500 | SSA | SSA-2406-H7478 | 2024-Q4 | 98.96 | 4.84 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019745 | Tirzepatide | HJ | HJ-2502-P3591 | 2025-Q1 | 99.12 | 2.23 | 107.0 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020945 | Ipamorelin | CPC | CPC-2503-J2830 | 2025-Q1 | 98.68 | 7.09 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-020882 | Kisspeptin-10 | CPC | CPC-2411-W1680 | 2024-Q4 | 97.92 | 4.06 | 102.0 | Buyer-sourced | 2 | FAIL |
| AX-2025-019839 | Retatrutide | SWB | SWB-2411-R4540 | 2025-Q1 | 97.50 | 3.83 | 101.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019512 | Humanin (HNG) | Homopeptide | HOMO-2408-A1230 | 2025-Q1 | 99.35 | 5.56 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021004 | GHRP-6 | WXT | WXT-2411-G3549 | 2024-Q4 | 99.48 | 3.58 | 90.5 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019264 | Exenatide | TFC | TFC-2409-W5949 | 2024-Q4 | 99.93 | 2.01 | 101.1 | Supplier-supplied | 0 | PASS |
| AX-2025-019194 | ARA-290 | TFC | TFC-2410-N5362 | 2024-Q4 | 99.87 | 3.34 | 90.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018526 | Survodutide | WWB | WWB-2408-T3710 | 2024-Q4 | 98.67 | 3.67 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020723 | GHRP-6 | SGN | SGN-2411-N9088 | 2025-Q1 | 98.41 | 3.98 | 107.0 | Buyer-sourced | 1 | FAIL |
| AX-2025-020375 | BPC-157 | MKM | MKM-2405-C3582 | 2024-Q4 | 99.66 | 4.08 | 105.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019089 | TB-500 | JEEP | JEEP-2407-K3892 | 2024-Q4 | 98.85 | 5.34 | 96.4 | Supplier-supplied | 2 | FAIL |
| AX-2025-018994 | Oxytocin | FGP | FGP-2406-W1827 | 2024-Q4 | 99.55 | 4.26 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020217 | Hexarelin | GGPeps | GGPE-2410-U1370 | 2024-Q4 | 98.90 | 4.66 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-019524 | L-Glutathione (reduced) | Homopeptide | HOMO-2501-D9486 | 2025-Q1 | 98.71 | 8.88 | 100.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019361 | LL-37 | TFC | TFC-2410-N7616 | 2025-Q1 | 98.30 | 3.98 | 94.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020726 | Semaglutide | SGN | SGN-2409-F8648 | 2024-Q4 | 98.11 | 4.69 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020089 | Retatrutide | GGPeps | GGPE-2411-R7895 | 2024-Q4 | 99.49 | 5.54 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019046 | Retatrutide | JEEP | JEEP-2411-F3745 | 2024-Q4 | 97.98 | 5.48 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018829 | CJC-1295 (no DAC) | QSC | QSC-2410-L8549 | 2024-Q4 | 98.65 | 6.41 | 100.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2024-005494 | CJC-1295 with DAC | BCH | BCH-2406-E7351 | 2024-Q4 | 98.58 | 4.77 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2024-004528 | Ipamorelin | FGP | FGP-2409-T2292 | 2024-Q4 | 99.68 | 4.32 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004667 | Semaglutide | TFC | TFC-2409-S7358 | 2024-Q4 | 99.39 | 3.31 | 96.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005031 | Semaglutide | GGPeps | GGPE-2410-L1879 | 2024-Q4 | 98.25 | 3.75 | 101.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2024-005443 | BPC-157 | WXT | WXT-2411-F5848 | 2024-Q4 | 98.21 | 5.37 | 96.2 | Supplier-supplied | 3 | MARGINAL |
| AX-2024-004985 | NAD+ | GGPeps | GGPE-2405-A1540 | 2024-Q4 | 97.58 | 7.92 | 95.6 | Buyer-sourced | 0 | PASS |
| AX-2024-004810 | SS-31 (Elamipretide) | Homopeptide | HOMO-2410-K1981 | 2024-Q4 | 99.74 | 3.20 | — | Supplier-supplied | 0 | PASS |
| AX-2024-004568 | Retatrutide | JEEP | JEEP-2411-F3745 | 2024-Q4 | 98.41 | 4.68 | 101.9 | Supplier-supplied | 1 | MARGINAL |